The Diabetes Prevention Program.
Muniyappa
Ranganath
R
El-Atat
Fadi
F
Aneja
Ashish
A
McFarlane
Samy I
SI
D000328:Adult; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D002839:Chromans / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000453:epidemiology / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D015994:Incidence; D008019:Life Style; D008687:Metformin / Q000627:therapeutic use*; D009017:Morbidity; D012307:Risk Factors; D013844:Thiazoles / Q000627:therapeutic use*; D045162:Thiazolidinediones; D000077288:Troglitazone
D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D008687:Metformin; D000077288:Troglitazone